{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:36:20Z","timestamp":1740137780946,"version":"3.37.3"},"reference-count":17,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1055\/s-0044-1786176","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T22:46:15Z","timestamp":1714171575000},"page":"625-627","source":"Crossref","is-referenced-by-count":1,"title":["Anticoagulation in Patients with Mechanical Heart Valves: Less Is More?"],"prefix":"10.1055","volume":"124","author":[{"given":"Daniela","family":"Poli","sequence":"additional","affiliation":[{"name":"Thrombosis Centre \u2013 M. Aterotrombotiche Azienda Ospedaliero Universitaria Careggi, Firenze, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-2897","authenticated-orcid":false,"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[{"name":"Research Center on Thromboembolic Disorders and Antithrombotic Therapies - ASST Lariana, University of Insubria, Como, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Tosetto","sequence":"additional","affiliation":[{"name":"Hematology Department, Hemophilia and Thrombosis Center, Vicenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","article-title":"Epidemiology of valvular heart disease in the adult","volume":"8","author":"B Iung","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"J W Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"07","key":"ref3","first-page":"EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an On-X mechanical aortic valve","volume":"2","author":"T Y Wang","year":"2023","journal-title":"NEJM Evid"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"D A Watkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0043-1777827","article-title":"Outcomes of patients with a mechanical heart valve and poor anticoagulation control on warfarin","volume":"124","author":"I Johansson","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2016.06.026","article-title":"Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: a nationwide population-based study","volume":"181","author":"A Labaf","year":"2016","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2018.04.042","article-title":"Mechanical prosthetic heart valves: quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study","volume":"267","author":"D Poli","year":"2018","journal-title":"Int J Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2022.09.018","article-title":"Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: observations on quality of anticoagulation and thrombotic risk","volume":"219","author":"N Erba","year":"2022","journal-title":"Thromb Res"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.061523","article-title":"Frequency of adverse events in patients with poor anticoagulation: a meta-analysis","volume":"176","author":"N Oake","year":"2007","journal-title":"CMAJ"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1538-7836.2008.02959.x","article-title":"An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage","volume":"6","author":"L Poller","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2009.05.046","article-title":"Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years","volume":"54","author":"D Poli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjh.16528","article-title":"Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study","volume":"190","author":"D Pastori","year":"2020","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"602S","DOI":"10.1378\/chest.114.5_Supplement.602S","article-title":"Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves","volume":"114","author":"P D Stein","year":"1998","journal-title":"Chest"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.94.9.2107","article-title":"AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves","volume":"94","author":"J Acar","year":"1996","journal-title":"Circulation"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"C M Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"60","author":"A Vahanian","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"e0144314","DOI":"10.1371\/journal.pone.0144314","article-title":"Center-related determinants of VKA anticoagulation quality: prospective a. multicenter evaluation","volume":"10","author":"A Tosetto","year":"2015","journal-title":"PLoS One"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1786176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:18:17Z","timestamp":1730801897000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1786176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":17,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2024,6,25]]},"published-print":{"date-parts":[[2024,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1786176","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"type":"print","value":"0340-6245"},{"type":"electronic","value":"2567-689X"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}